Daily Equity Reports 06 Nov 2018

1. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 06TH NOVEMBER 2018 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

2. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report INDIANFACE INDIAN MARKET PREVIOUS ! 34950.92 INDIANEQUITYBENCHMARK:- At the close of market hours, the Sensex was down 64.02 points at 34,947.63, while 10524.00 the Nifty was down 29 points at 10,524. About 1324 shares ASIAN MARKET have advanced, 1292 shares declined, and 155 shares are PREVIOUS unchanged. SBI, Axis Bank, Reliance Industries, Wipro and Coal NIKKEI 21898.99 India are the top gainers, while IndusInd Bank, NTPC, Power 25934.39 Grid Corp, Hero Motocorp and Adani Ports lost the most on the 2096.00 Sensex. GLOBALFACE SECTORIAL INDICES CHANGE (%) ! 10766.35 -0.15 AsianMarket- Asianmarketsfinishedbroadlylowertoday withsharesinHongKongleadingtheregion.TheHangSeng is down 2.33% while Japan's Nikkei 225 is off 1.55% and China'sShanghaiCompositeislowerby0.41%. -0.22 -0.30 ! U.S.Market-AlleyesonUSmidtermelections. -0.19 ! 25747.95 0.18 Europeanmarkets- European markets are higher today with shares in France leading the region. The CAC 40 is up 0.12% while Germany's DAX is up 0.10% and London's FTSE 100 is up 0.08%. CHANGE (%) 3.77 UPL 2.13 AXIS BANK 2.04 WIPRO 1.74 TOP LOSERS CLOSE CHANGE (%) CIPLA -7.35 -5.16 IBULHSGFIN -4.35 1484.25 -3.73 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

3. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report NIFTYSPOT MARKET MOVERS UPSIDE STRATEGY SCRIPT CLOSE (%) 3.59 1023.90 PIVOT POINTS P 10519 3.56 R1 R2 10600 RESISTANCE R1-10600 R2-10780 R3 10681 10357 10438 10481 10562 3.45 SBI SUPPORT S1-10480 S2-10350 2203.80 2.50 PEL CLOSE (%) -7.33 -5.50 INDIAN OIL -4.24 IBULHSGFIN -4.18 NET BULLISH (CR.) PIVOT POINTS P 25756 9069.85 S3 S1 25639 R1 25939 R2 R3 25156 25456 DII 5168.37 RESISTANCE BANK NIFTY NSE TOTALS ADVANCE BANK NIFTY 7 5 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

4. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report MARKET TALKS ! JetAirwaysgetsintoanotherroundof! estimates Shares of Cipla down 7% on Monday after the company’s numbers for the second quarter of FY19 missedtheconsensusexpectations.Cipla’srevenuein Q2FY19 declined 1.7% yoy to Rs4,011.9cr vs. Rs4,082.4crinQ2FY18.EBITDAinthequarterdeclined 12.7% yoy to Rs702.2cr in Q2FY19 vs. Rs804.4cr in Q2FY18.EBITDAmarginsstoodat17.5%,down220bps, inQ2FY19vs.19.7%inQ2FY18and 18.4%inQ1FY19. PAT declined 10.8% yoy to Rs377cr in Q2FY19 vs. Rs422.6cr in Q2FY18. All numbers are below the consensus expectations. The consensus estimate of revenuegrowthwas8.4%,EBITDAmarginwas~19%, whilePATwasexpectedtobeatRs468cr. discussionswithTATAsforstakesale AccordingtomediareportsonNov5,2018,JetAirwaysis inthesecond round ofdiscussionswith TATA Groupfor stakesaleinthecompany.Earlier,almostaweekback,Jet Airways promoter Mr Naresh Goyal had approached Reliance Industries’ Mukesh Ambani and TATA Group’s Ratan Tata for raising capital through stake sale (Read more).However,MrGoyaldidnotgetanyresponsefrom MrAmbani,whileTATAGrouphadsoughtfullcontrolon theairline.IfthedealgoesthroughJetAirwaysisexpected to get merged with Vistara (TATA's JV with Singapore AirlinesLimited).Inaddition,TATAmaybuyEtihad’sstake inJetAirways.MrGoyalcurrentlyholds51%stakeinJet Airways,whileAbuDhabi-basedEtihadAirwaysholds24% inthecompany. ! AdaniTransmissiontoacquireKECBikaner SikarTransmission ThecompanyinkedanagreementwithKECInternational for purchasing entire stake Transmission.AsperaSharePurchaseAgreement(SPA), theacquisitionwillbevaluedatRs227.5crandissubjectto regulatoryandotherapprovals,thecompanysaidinapress notetoexchangesonSaturday.. in KEC Bikaner Sikar ! LupingetsUSFDAnodforDoxercalciferol injection PharmamajorLupinannouncedthatithasreceivedapprovalfor itsDoxercalciferolInjection,4mcg/2ml(2mcg/ml)Multi-dose VialsfromtheUSFDAtomarketagenericversionofSanofi Genzyme'sHectorolInjection.Therearealready7approved ANDAsintheproduct.CompetitorsincludeAkorn,Amneal, Hospira,Sandoz,etc. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

5. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Capitalstars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. Capitalstars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

6. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Intraday stock tips Financial advisory company Share market company * Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. * CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

7. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.